salicylanilide has been researched along with Tuberculosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranyai, Z; Bősze, S; Janďourek, O; Krátký, M; Novotná, E; Stolaříková, J; Vinšová, J | 1 |
| Baranyai, Z; Bősze, S; Dávid, S; Krátký, M; Senoner, Z; Stolaříková, J; Szabó, E; Vinšová, J; Vosátka, R | 1 |
| Férriz, JM; Imramovský, A; Kunc, F; Stolaríková, J; Vavríková, E; Vávrová, K; Vinsová, J | 1 |
3 other study(ies) available for salicylanilide and Tuberculosis
| Article | Year |
|---|---|
Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Topics: Antitubercular Agents; Carbamates; Hep G2 Cells; Humans; Isocitrate Lyase; Mycobacterium tuberculosis; Phenols; Salicylanilides; Tuberculosis | 2019 |
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rats; Salicylanilides; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuftsin | 2017 |
Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Carbamates; Cell Line; Cell Proliferation; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2010 |